19 . 04 . 2018

Fun and sports for children with CHD


Fun and sports for children with CHD

A Xeltis team joined children with congenital heart conditions and their families for a playful day focused on activities and sport organized by Dutch patient association Harteraad (previously De Hart&Vaatgroep) on Sunday April 15 in Eindhoven, Netherlands. While games entertained children aged 10-18, experts were on hand to talk with their families about safe and suitable […]

Scroll inside box for more news
Xeltis CEO wins Global Business Excellence Award for Outstanding Executive
17 . 04 . 2018

Xeltis CEO wins Global Business Excellence Award for Outstanding Executive

Xeltis’ restorative aortic valves show promise at HVS
13 . 04 . 2018

Xeltis’ restorative aortic valves show promise at HVS

Xeltis CEO on late-stage financing at Medtech Strategist Summit
12 . 04 . 2018

Xeltis CEO on late-stage financing at Medtech Strategist Summit

Xeltis nominated for the Swiss Medtech Award
11 . 04 . 2018

Xeltis nominated for the Swiss Medtech Award

Xeltis pays tribute to Arnaud de Ménibus
10 . 04 . 2018

Xeltis pays tribute to Arnaud de Ménibus

Xeltis’ restorative aortic valves at HVS
6 . 04 . 2018

Xeltis’ restorative aortic valves at HVS

Xeltis CEO on leading start-ups to success at START Summit
16 . 03 . 2018

Xeltis CEO on leading start-ups to success at START Summit

Prof. Carrel brings Xeltis’ restorative heart valves to ACC 2018
12 . 03 . 2018

Prof. Carrel brings Xeltis’ restorative heart valves to ACC 2018

Xeltis’ innovation in the spotlight at CRT2018
2 . 03 . 2018

Xeltis’ innovation in the spotlight at CRT2018

Xeltis joining forces on HVD Awareness Day
22 . 02 . 2018

Xeltis joining forces on HVD Awareness Day

Xeltis is in Swiss Venture Capital Report
1 . 02 . 2018

Xeltis is in Swiss Venture Capital Report

Webinar outlines new horizons for pulmonary heart valve therapy
30 . 01 . 2018

Webinar outlines new horizons for pulmonary heart valve therapy

Webinar: A future without reoperations?
26 . 01 . 2018

Webinar: A future without reoperations?

The Xplore-2 feasibility study under way in the US
26 . 01 . 2018

The Xplore-2 feasibility study under way in the US

Preclinical Data on Xeltis’ Pulmonary Valve Published in <em>JTCVS</em>
16 . 01 . 2018

Preclinical Data on Xeltis’ Pulmonary Valve Published in JTCVS

Our corporate Christmas gift this year…
19 . 12 . 2017

Our corporate Christmas gift this year…

Preclinical data on Xeltis’ Aortic Valve published in <em>EuroIntervention</em>
5 . 12 . 2017

Preclinical data on Xeltis’ Aortic Valve published in EuroIntervention

Xeltis CFO speaks at Swiss IPO event
29 . 11 . 2017

Xeltis CFO speaks at Swiss IPO event

Xeltis and Dutch Noord-Brabant Province meet to boost regional cooperation
17 . 11 . 2017

Xeltis and Dutch Noord-Brabant Province meet to boost regional cooperation

Xeltis Closes €45 Million Series C Financing
15 . 11 . 2017

Xeltis Closes €45 Million Series C Financing

Positive Preclinical Data on Xeltis Pulmonary Valve to be published in <i>Eurointervention</i>
8 . 11 . 2017

Positive Preclinical Data on Xeltis Pulmonary Valve to be published in Eurointervention

Xeltis’ Aortic Valve preclinical results shared at TCT 2017
1 . 11 . 2017

Xeltis’ Aortic Valve preclinical results shared at TCT 2017

TCT 2017 to feature restorative heart valve therapy discussion
30 . 10 . 2017

TCT 2017 to feature restorative heart valve therapy discussion

Xeltis’ Preclinical Aortic Valve Data at PCR London Valves
26 . 09 . 2017

Xeltis’ Preclinical Aortic Valve Data at PCR London Valves

ETR featured in peer-reviewed journal EuroIntervention
25 . 09 . 2017

ETR featured in peer-reviewed journal EuroIntervention

Laurent Grandidier to speak at UBS Disruptive Technology Summit
25 . 09 . 2017

Laurent Grandidier to speak at UBS Disruptive Technology Summit

Xeltis CTO on the future of heart valve therapy at PCR London Valves
22 . 09 . 2017

Xeltis CTO on the future of heart valve therapy at PCR London Valves

Positive progression of ETR clinical trials at WCPCCS
20 . 07 . 2017

Positive progression of ETR clinical trials at WCPCCS

Patients inspire the Xeltis Team
7 . 07 . 2017

Patients inspire the Xeltis Team

7 Vidi grants reward Xeltis’ long-standing academic research partner
16 . 06 . 2017

7 Vidi grants reward Xeltis’ long-standing academic research partner

Xeltis’ RestoreX technology to be presented at TVT 2017
14 . 06 . 2017

Xeltis’ RestoreX technology to be presented at TVT 2017

Excellent Preclinical Performance of Restorative Aortic Valve
10 . 06 . 2017

Excellent Preclinical Performance of Restorative Aortic Valve

Excellent preclinical data show RestoreX potential for restorative vascular treatment
6 . 06 . 2017

Excellent preclinical data show RestoreX potential for restorative vascular treatment

Xeltis’ restorative heart valve therapy featured at EuroPCR
17 . 05 . 2017

Xeltis’ restorative heart valve therapy featured at EuroPCR

EuroPCR to host first ETR dedicated plenary session
15 . 05 . 2017

EuroPCR to host first ETR dedicated plenary session

Xeltis CTO at Biomedica Summit
8 . 05 . 2017

Xeltis CTO at Biomedica Summit

Professor Lange joins Xeltis’ Medical Advisory Board
2 . 05 . 2017

Professor Lange joins Xeltis’ Medical Advisory Board

Xeltis wins Gold Edison Award in medical technology
21 . 04 . 2017

Xeltis wins Gold Edison Award in medical technology

Potential of new cardiovascular restoration strategies presented at SFB
5 . 04 . 2017

Potential of new cardiovascular restoration strategies presented at SFB

Xeltis data on cardiovascular restoration with electrospun polymers at SFB
4 . 04 . 2017

Xeltis data on cardiovascular restoration with electrospun polymers at SFB

Xeltis shortlisted for Company of the Year
15 . 03 . 2017

Xeltis shortlisted for Company of the Year

<em>Science TM on ETR</em>: “Biology and engineering integrated at staggering level”
7 . 03 . 2017

Science TM on ETR: “Biology and engineering integrated at staggering level”

Preclinical heart valve restoration study in Biomaterials
3 . 03 . 2017

Preclinical heart valve restoration study in Biomaterials

Positive two-year preclinical data on Xeltis’ PV at HVS meeting
2 . 03 . 2017

Positive two-year preclinical data on Xeltis’ PV at HVS meeting

Xeltis clinical data published in JTCVS
24 . 02 . 2017

Xeltis clinical data published in JTCVS

“Xeltis has the potential to redefine heart valve replacement therapy”
21 . 02 . 2017

“Xeltis has the potential to redefine heart valve replacement therapy”

Leading cardiologist to present Xeltis’ bioabsorbable valve at CRT 2017
19 . 02 . 2017

Leading cardiologist to present Xeltis’ bioabsorbable valve at CRT 2017

Xeltis CTO’s entrepreneurial perspective at Innovation for Healthcare
14 . 02 . 2017

Xeltis CTO’s entrepreneurial perspective at Innovation for Healthcare

Xeltis is a 2017 Edison Awards Finalist
9 . 02 . 2017

Xeltis is a 2017 Edison Awards Finalist

“How to build a successful med-tech company”
8 . 02 . 2017

“How to build a successful med-tech company”

FDA gives Xeltis go ahead to begin trials in the USA
31 . 01 . 2017

FDA gives Xeltis go ahead to begin trials in the USA

Season’s Greetings: A Word from the CEO
23 . 12 . 2016

Season’s Greetings: A Word from the CEO

Introducing the RestoreX brand
21 . 12 . 2016

Introducing the RestoreX brand

Xeltis completes patient enrollment in Xplore-I trial
19 . 12 . 2016

Xeltis completes patient enrollment in Xplore-I trial

Xeltis receives nomination for 2017 Edison Awards
14 . 12 . 2016

Xeltis receives nomination for 2017 Edison Awards

Xeltis expands Clinical Advisory Board’s expertise with significant EU and US appointments
22 . 11 . 2016

Xeltis expands Clinical Advisory Board’s expertise with significant EU and US appointments

Xeltis announces multidisciplinary Scientific Advisory Board of global leading experts
1 . 11 . 2016

Xeltis announces multidisciplinary Scientific Advisory Board of global leading experts

Xeltis to introduce aortic valve program at TCT 2016 New Technology Forum
28 . 10 . 2016

Xeltis to introduce aortic valve program at TCT 2016 New Technology Forum

Three patients successfully implanted with Xeltis’ bioabsorbable pulmonary valve in Asia
21 . 10 . 2016

Three patients successfully implanted with Xeltis’ bioabsorbable pulmonary valve in Asia

Xeltis two steps closer to redefining heart valve replacement: highlights from EACTS 2016
10 . 10 . 2016

Xeltis two steps closer to redefining heart valve replacement: highlights from EACTS 2016

Two-year clinical data show positive functionality of Xeltis’ bioabsorbable cardiovascular device
5 . 10 . 2016

Two-year clinical data show positive functionality of Xeltis’ bioabsorbable cardiovascular device

First Heart Valve Enabling Heart Restoration Successfully Implanted
2 . 10 . 2016

First Heart Valve Enabling Heart Restoration Successfully Implanted

Xeltis data set to make an impact at EACTS 2016
1 . 10 . 2016

Xeltis data set to make an impact at EACTS 2016

Excitement builds about Xeltis’ potential from MedTech Strategist front cover
30 . 09 . 2016

Excitement builds about Xeltis’ potential from MedTech Strategist front cover

Leading cardiovascular experts join Xeltis Clinical Advisory Board
19 . 09 . 2016

Leading cardiovascular experts join Xeltis Clinical Advisory Board

Xeltis technology enables cardiovascular regeneration in high blood pressure, preclinical data showed at ISACB
9 . 09 . 2016

Xeltis technology enables cardiovascular regeneration in high blood pressure, preclinical data showed at ISACB

Martijn Cox: Bringing Xeltis technology to life
7 . 09 . 2016

Martijn Cox: Bringing Xeltis technology to life

Xeltis awarded extended ISO certification
8 . 07 . 2016

Xeltis awarded extended ISO certification

Xeltis joins launch of Dutch Regenerative Medicine institute
7 . 07 . 2016

Xeltis joins launch of Dutch Regenerative Medicine institute

Xeltis Celebrates 10th Anniversary
1 . 07 . 2016

Xeltis Celebrates 10th Anniversary

Meet the Xeltis team at Eindhoven Expat Fair
10 . 06 . 2016

Meet the Xeltis team at Eindhoven Expat Fair

Xeltis in-vivo data demonstrating Endogenous Tissue Restoration presented at WBC
21 . 05 . 2016

Xeltis in-vivo data demonstrating Endogenous Tissue Restoration presented at WBC

Xeltis late-breaking data at AATS set stage for the development of first bioabsorbable heart valve
17 . 05 . 2016

Xeltis late-breaking data at AATS set stage for the development of first bioabsorbable heart valve

Xeltis pulmonary valve on track for 2016 clinical trials – stated CEO at PCR Innovators Day
16 . 05 . 2016

Xeltis pulmonary valve on track for 2016 clinical trials – stated CEO at PCR Innovators Day

Xeltis bioabsorbable cardiovascular technology clinical data are late breaker at AATS
12 . 05 . 2016

Xeltis bioabsorbable cardiovascular technology clinical data are late breaker at AATS

Renowned start-up advocate met with Xeltis co-founder
10 . 05 . 2016

Renowned start-up advocate met with Xeltis co-founder

Laurent Grandidier in the 2016 Medicine Maker Power List 100
29 . 04 . 2016

Laurent Grandidier in the 2016 Medicine Maker Power List 100

Xeltis selected to present at EuroPCR Innovators Day
15 . 04 . 2016

Xeltis selected to present at EuroPCR Innovators Day

Innovation in MedTech invites Xeltis CEO back to present
14 . 04 . 2016

Innovation in MedTech invites Xeltis CEO back to present

US FDA granted Humanitarian Use Device for Xeltis pulmonary valve
23 . 03 . 2016

US FDA granted Humanitarian Use Device for Xeltis pulmonary valve

Xeltis pulmonary conduit data presented at HVS
17 . 03 . 2016

Xeltis pulmonary conduit data presented at HVS

Xeltis to present to leading investors at European forum
15 . 03 . 2016

Xeltis to present to leading investors at European forum

Xeltis CEO to present at leading BioCapital event
3 . 03 . 2016

Xeltis CEO to present at leading BioCapital event

Heart Awareness Month
24 . 02 . 2016

Heart Awareness Month

Xeltis’ QMS received ISO certification
18 . 02 . 2016

Xeltis’ QMS received ISO certification

Supporting CHD Awareness Week 2016
11 . 02 . 2016

Supporting CHD Awareness Week 2016

Xeltis appoints new CFO
2 . 02 . 2016

Xeltis appoints new CFO

Dutch figurehead Professor Jan Raaijmakers visits Xeltis
29 . 01 . 2016

Dutch figurehead Professor Jan Raaijmakers visits Xeltis

Leading Research Program NRP 63 featuring Xeltis’ technology
28 . 01 . 2016

Leading Research Program NRP 63 featuring Xeltis’ technology

How Xeltis overcame medtech financial challenges
22 . 01 . 2016

How Xeltis overcame medtech financial challenges

Xeltis-led research published in Tissue Engineering Part A
6 . 01 . 2016

Xeltis-led research published in Tissue Engineering Part A

Xeltis extends series B financing to €30M, signing off transformational year
17 . 12 . 2015

Xeltis extends series B financing to €30M, signing off transformational year

Nobel Laureate Professor Lehn visiting Xeltis
9 . 12 . 2015

Nobel Laureate Professor Lehn visiting Xeltis

Xeltis CEO Laurent Grandidier receives Award for Best CEO in Medical Devices
5 . 12 . 2015

Xeltis CEO Laurent Grandidier receives Award for Best CEO in Medical Devices

Xeltis nominates Michel Darnaud as new Chairman
19 . 11 . 2015

Xeltis nominates Michel Darnaud as new Chairman

The positive economics of the Xeltis technology
17 . 11 . 2015

The positive economics of the Xeltis technology

Xeltis completed second feasibility clinical trial on novel bioabsorbable cardiovascular device technology
10 . 11 . 2015

Xeltis completed second feasibility clinical trial on novel bioabsorbable cardiovascular device technology

Eliane Schutte joins the Xeltis Executive Team as Chief Development Officer
5 . 11 . 2015

Eliane Schutte joins the Xeltis Executive Team as Chief Development Officer

First ever bioabsorbable heart conduit by Xeltis implanted two years ago
23 . 10 . 2015

First ever bioabsorbable heart conduit by Xeltis implanted two years ago

Xeltis-led research on supramolecular polymer bioabsorbtion in Acta Biomaterialia
23 . 10 . 2015

Xeltis-led research on supramolecular polymer bioabsorbtion in Acta Biomaterialia

A heart-racing day for Heartbeat Foundation
19 . 10 . 2015

A heart-racing day for Heartbeat Foundation

Xeltis one of 15 most promising private medtech companies globally
14 . 10 . 2015

Xeltis one of 15 most promising private medtech companies globally

Martijn Cox on Xeltis research in Brabants Dagblad
30 . 09 . 2015

Martijn Cox on Xeltis research in Brabants Dagblad

Xeltis at Les Journées de Moscou, L’Obs’s Moscow Forum
24 . 09 . 2015

Xeltis at Les Journées de Moscou, L’Obs’s Moscow Forum

Xeltis proudly presents short movie of its first charity event
13 . 08 . 2015

Xeltis proudly presents short movie of its first charity event

Omroep Brabant portrays Xeltis in a video reportage
4 . 08 . 2015

Omroep Brabant portrays Xeltis in a video reportage

Cooperation is essential: Xeltis appeared in renowned Netherlands Heart Journal June issue
9 . 07 . 2015

Cooperation is essential: Xeltis appeared in renowned Netherlands Heart Journal June issue

Xeltis completes first study of Endogenous Tissue Restoration technology
19 . 05 . 2015

Xeltis completes first study of Endogenous Tissue Restoration technology

Xeltis nominates Michel Darnaud for election to its Board of Directors
18 . 05 . 2015

Xeltis nominates Michel Darnaud for election to its Board of Directors

Xeltis presenting on PCR Innovators day
11 . 05 . 2015

Xeltis presenting on PCR Innovators day

Xeltis’ CEO Laurent Grandidier meets Willem-Alexander, King of the Netherlands
28 . 04 . 2015

Xeltis’ CEO Laurent Grandidier meets Willem-Alexander, King of the Netherlands

Financieele Dagblad portrays Xeltis and its Dutch-Swiss culture
9 . 03 . 2015

Financieele Dagblad portrays Xeltis and its Dutch-Swiss culture

Le Temps writes about revolutionary approaches in heart surgery
17 . 02 . 2015

Le Temps writes about revolutionary approaches in heart surgery

Successful Start-Ups in the Netherlands: Xeltis is mentioned in Link Magazine
17 . 02 . 2015

Successful Start-Ups in the Netherlands: Xeltis is mentioned in Link Magazine

Xeltis welcomes Boris Warnack as a new member of the Executive Team
1 . 02 . 2015

Xeltis welcomes Boris Warnack as a new member of the Executive Team

Four million Euro to develop new vascular graft for kidney dialysis
19 . 01 . 2015

Four million Euro to develop new vascular graft for kidney dialysis

Xeltis’ investment round in Biotech Finances
12 . 12 . 2014

Xeltis’ investment round in Biotech Finances

Eindhovens Dagblad writes about Xeltis’ Series B financing
11 . 12 . 2014

Eindhovens Dagblad writes about Xeltis’ Series B financing

Xeltis closes EURO 27 million / USD 34 million series B Financing
2 . 12 . 2014

Xeltis closes EURO 27 million / USD 34 million series B Financing

Xeltis featured by Dutch television program
7 . 11 . 2014

Xeltis featured by Dutch television program

Dutch Minister of Finance visits Xeltis
4 . 11 . 2014

Dutch Minister of Finance visits Xeltis

Professor Schoen on supramolecular chemistry in Cardiology Today
3 . 06 . 2014

Professor Schoen on supramolecular chemistry in Cardiology Today

Xeltis’ recent article in Cardiology Today:
19 . 05 . 2014

Xeltis’ recent article in Cardiology Today:

Xeltis on the frontpage of News Medical
26 . 03 . 2014

Xeltis on the frontpage of News Medical

MDD leads with Xeltis story
12 . 03 . 2014

MDD leads with Xeltis story

Xeltis Completes Enrolment in World’s First Study of Spontaneous Tissue Growth
22 . 02 . 2014

Xeltis Completes Enrolment in World’s First Study of Spontaneous Tissue Growth

Xeltis Appoints Nobel Prize Winner  Prof. Jean-Marie Lehn To Its Advisory Board
7 . 01 . 2014

Xeltis Appoints Nobel Prize Winner Prof. Jean-Marie Lehn To Its Advisory Board

6 . 01 . 2014

6 . 01 . 2014

New CFO joins Xeltis’ awesome team
21 . 11 . 2013

New CFO joins Xeltis’ awesome team

Innovation in a changing medtech landscape
5 . 11 . 2013

Innovation in a changing medtech landscape

Xeltis CEO speaks at Life Science Week
9 . 10 . 2013

Xeltis CEO speaks at Life Science Week

Eindhoven – The world’s most inventive city
19 . 08 . 2013

Eindhoven – The world’s most inventive city

Xeltis wins ‘Next Gem Award in Medtech’
2 . 04 . 2013

Xeltis wins ‘Next Gem Award in Medtech’

Xeltis Team wishes all seasons greetings
5 . 03 . 2013

Xeltis Team wishes all seasons greetings

Xeltis selected as Hot Pick of the Month and featured in Clinica
8 . 02 . 2013

Xeltis selected as Hot Pick of the Month and featured in Clinica

Xeltis Director of R&D chosen to represent “innovation”
7 . 02 . 2013

Xeltis Director of R&D chosen to represent “innovation”

Xeltis re-launches website
5 . 02 . 2013

Xeltis re-launches website

Xeltis CEO Laurent Grandidier presents at two prestigious conferences
5 . 02 . 2013

Xeltis CEO Laurent Grandidier presents at two prestigious conferences

Xeltis 25 European medtech startups
5 . 02 . 2013

Xeltis 25 European medtech startups

Latest Tweets

Scroll inside box for more tweets

Latest Tweets

LinkedIn Posts

Scroll inside box for more posts

    LinkedIn Company Updates

  • 8 Days Agoview on linkedin

    Xeltis

    Xeltis teamed up with Dutch patient association Harteraad for an active and fun day in Eindhoven, Netherlands. Most children with congenital heart disease can conduct an active life”, explained Harry van der Zaag, department head from Harteraad, “it is important to understand what the correct boundaries should be.” www.xeltis.com/news

  • 10 Days Agoview on linkedin

    Xeltis

    Today at MedTech Strategist Laurent Grandidier explains the key elements needed for achieving financial success: “Planning, vision, dedication and hard-work are central to securing your future" www.Xeltis.com/news

  • 10 Days Agoview on linkedin

    Xeltis

    Xeltis CEO Laurent Grandidier has been voted Outstanding Executive at the 2018 Global Business Excellence Awards in recognition of his leadership skills. Grandidier won the accolade for his accomplishments as “an outstanding social entrepreneur who is revolutionizing cardiovascular treatment with restorative technology.” www.xeltis.com/news

  • 11 Days Agoview on linkedin

    Xeltis

    CEO @Laurent Grandidier is speaking tomorrow as part of the MedTech Strategist investor panel at #InnovationDublin2018 at 3pm. Learn more about Laurent here https://lnkd.in/ee7EekE and the opportunity here: http://xeltis.com/news

  • 14 Days Agoview on linkedin

    Xeltis

    Preclinical data on Xeltis’ restorative aortic valve technology showed promise at the HVS cardiology meeting in New York on April 13 in a presentation by Dr Gregory P. Fontana, MD, National Medical Director for Cardiovascular Research, at the Hospital Corporation of America, Nashville, Tennessee, (U.S.). The 12-month data from in-vitro and in-vivo studies suggest that Xeltis’ technology could potentially be used for various heart valve designs, including transfemoral, and benefit younger patients. www.xeltis.com/news